What amount sold does ProVet Investment Holdings, LLC report in Form D filings?

The latest linked filings report $5.5M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was ProVet Investment Holdings, LLC's most recent SEC filing?

ProVet Investment Holdings, LLC's most recent Form D filing was on 2018-07-23.

How many investors does ProVet Investment Holdings, LLC have?

The most recent Form D filing lists 49 investor(s).

What type of securities does ProVet Investment Holdings, LLC offer?

ProVet Investment Holdings, LLC's SEC Form D filings indicate equity offerings.

ProVet Investment Holdings, LLC

CIK: 0001678556·Pharmaceuticals·CHICAGO, IL·Limited Liability Company·Founded 2016

Reported Sold

$5,510,576

Total Filings

Identified Offerings

Last Filed

Jul 23, 2018

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Jul 23, 2018Form D — New notice

Reported sold: $360,576 · Target: $360,576

Rule 506(b)·49 investors

Jun 30, 2016Form D — New notice

Reported sold: $5,150,000 · Target: $5,150,000

Rule 506(b)·51 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$5,510,576

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Promus Equity Partners, LLC

Related Person

Appears on 1 filing

Equity Partners, LLC Promus

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 23, 2018	New	$360,576	$360,576	49
Jun 30, 2016	New	$5,150,000	$5,150,000	51

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Pagari Life Science Corp.

Pharmaceuticals

Offering target: $300,000

Filed May 12, 2026